| 发明名称 |
Treatment of metastatic renal cell carcinoma |
| 摘要 |
<p>Tumor metastases in cancer patients are inhibited by administration of a combination therapy including effective amounts of Interleukin-2 and a methylol transfer agent such as taurolidine, taurultam or mixtures thereof.</p> |
| 申请公布号 |
EP1201247(A2) |
申请公布日期 |
2002.05.02 |
| 申请号 |
EP20010309157 |
申请日期 |
2001.10.29 |
| 申请人 |
ED GEISTLICH SOEHNE AG FUER CHEMISCHE INDUSTRIE |
发明人 |
REDMOND, H. PAUL;PFIRRMANN, ROLF W. |
| 分类号 |
A61K38/20;A61K45/00;A61K31/549;A61K38/00;A61P35/00;A61P35/02;A61P35/04;(IPC1-7):A61K38/20 |
主分类号 |
A61K38/20 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
